ClinicalTrials.gov
ClinicalTrials.gov Menu

PhrenIc Nerve mappinG and Stimulation EP Catheter Study: PING-EP Study (PING-EP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01109641
Recruitment Status : Completed
First Posted : April 23, 2010
Last Update Posted : October 7, 2010
Sponsor:
Information provided by:
Medtronic Italia

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The PING-EP study is designed to evaluate electrode properties on phrenic nerve stimulation (PNS) in coronary sinus using a commercially available diagnostic electrophysiology catheter.

Condition or disease Intervention/treatment Phase
Heart Failure Device: diagnostic electrophysiology catheter Phase 4

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: PhrenIc Nerve mappinG and Stimulation EP Catheter Study: PING-EP Study
Study Start Date : February 2010
Actual Primary Completion Date : October 2010
Actual Study Completion Date : October 2010
Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
    Device: diagnostic electrophysiology catheter
    electrical measurements through a diagnostic electrophysiology catheter

Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Effect of electrode property on phrenic nerve stimulation (PNS) [ Time Frame: at implant ]
    Effect of electrode property on PNS in the cardiac veins


Secondary Outcome Measures :
  1. Effect of electrode configuration on phrenic nerve stimulation (PNS) [ Time Frame: at implant ]
  2. Electrode polarity effect on phrenic nerve stimulation (PNS) [ Time Frame: at implant ]
  3. Effect of electrode property on sensing (r-wave amplitude) [ Time Frame: at implant ]
  4. Incidence of phrenic nerve stimulation (PNS) in the cardiac veins [ Time Frame: at implant ]
    Incidence of PNS occurrence in different locations in the cardiac vein


Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subject is indicated for a cardiac resynchronization therapy-pacemaker or defibrillator (CRT-P/CRT-D) implant, for an upgrading from a previously implanted single/dual chamber pacemaker/implantable cardioverter (ICD) or for system revision requiring repositioning of the transvenous left ventricular (LV) lead
  • Patient has signed and dated the study-specific Patient Informed Consent form
  • Subject is at least 18 years of age

Exclusion Criteria:

  • Patient has a previous LV lead implanted not requiring repositioning
  • Pregnant woman
  • Patient is enrolled or planning to participate in any concurrent study, which would confound the results of this trial as determined by Medtronic, during the course of this clinical study
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01109641


Locations
Italy
Azienda Unità Socio Sanitaria di Dolo Mirano
Mirano, Venezia, Italy, 30035
Azienda Ospedaliero-Universitana di Bologna, Policlinico S. Orsola Malpighi
Bologna, Italy, 40138
Azienda Ospedaliero-universitaria Careggi
Firenze, Italy, 50141
Ospedale S. Maria della Misericordia
Rovigo, Italy, 45100
Sponsors and Collaborators
Medtronic Italia
Investigators
Principal Investigator: Mauro Biffi Policlinico S. Orsola Malpighi, Bologna, Italy
Principal Investigator: Francesco Zanon Ospedale S. Maria della Misericordia, Rovigo, Italy
Principal Investigator: Luigi Padeletti Azienda ospedaliero-universitaria Careggi, Firenze, Italy
Principal Investigator: Manuel Bertaglia Azienda Unità Socio Sanitaria di Dolo Mirano, Mirano (VE), Italy
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications:

Responsible Party: Francesco De Seta, Medtronic Italia
ClinicalTrials.gov Identifier: NCT01109641     History of Changes
Other Study ID Numbers: MDT-PINGEP
First Posted: April 23, 2010    Key Record Dates
Last Update Posted: October 7, 2010
Last Verified: October 2010

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases